These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35338095)

  • 1. Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.
    Annangi S; Coz-Yataco AO
    Respir Care; 2022 Apr; 67(4):440-447. PubMed ID: 35338095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV
    Kronborg T; Hangaard S; Cichosz SL; Hejlesen O
    Respir Care; 2019 Jan; 64(1):85-90. PubMed ID: 30578360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.
    Guerriero M; Caminati M; Viegi G; Senna G; Pomari C
    J Asthma; 2019 Jan; 56(1):27-33. PubMed ID: 29420087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, laboratory, and functional characteristics of asthma-COPD overlap in patients with a primary diagnosis of COPD.
    Queiroz APA; Fonseca FR; Rê A; Maurici R
    J Bras Pneumol; 2020; 47(1):e20200033. PubMed ID: 33174971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care.
    Izbicki G; Teo V; Liang J; Russell GM; Holland AE; Zwar NA; Bonevski B; Mahal A; Eustace P; Paul E; Phillips K; Wilson S; George J; Abramson MJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2745-2752. PubMed ID: 31819406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study.
    Matsumoto K; Seki N; Fukuyama S; Moriwaki A; Kan-o K; Matsunaga Y; Noda N; Yoshida M; Koto H; Takata S; Nakanishi Y; Kiyohara Y; Inoue H;
    Respir Investig; 2015 Jan; 53(1):22-9. PubMed ID: 25542600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Airflow Limitation Defined by Pre- and Post-Bronchodilator Spirometry in a Community-Based Health Checkup: The Hisayama Study.
    Fukuyama S; Matsumoto K; Kaneko Y; Kan-o K; Noda N; Tajiri-Asai Y; Nakano T; Ishii Y; Kiyohara Y; Nakanishi Y; Inoue H;
    Tohoku J Exp Med; 2016 Feb; 238(2):179-84. PubMed ID: 26888697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters.
    Kraemer R; Smith HJ; Gardin F; Barandun J; Minder S; Kern L; Brutsche MH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2487-2500. PubMed ID: 34511893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR; Thompson BR; Miller B; Borg BM
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
    Krishnan JA; Nibber A; Chisholm A; Price D; Bateman ED; Bjermer L; van Boven JFM; Brusselle G; Costello RW; Dandurand RJ; Diamant Z; Van Ganse E; Gouder C; van Kampen SC; Kaplan A; Kocks J; Miravitlles M; Niimi A; Pizzichini E; Rhee CK; Soriano JB; Vogelmeier C; Román-Rodriguez M; Carter V; D'Urzo AD; Roche N
    Ann Am Thorac Soc; 2019 Sep; 16(9):1143-1150. PubMed ID: 31162945
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and features of asthma-COPD overlap in the United States 2007-2012.
    Mendy A; Forno E; Niyonsenga T; Carnahan R; Gasana J
    Clin Respir J; 2018 Aug; 12(8):2369-2377. PubMed ID: 29873189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.
    Gong Z; Huang J; Xu G; Chen Y; Xu M; Ma Y; Zhao W; Wang Y; Liang J; Ou C; Liu L; Cai S; Zhao H
    Eur J Med Res; 2024 Feb; 29(1):97. PubMed ID: 38311782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
    Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
    COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.